ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0447

Is Systemic Vasculitis a Risk Factor for Myocardial Infarction? A Retrospective Cohort Study from the National Inpatient Sample

Kavin Raj1, Marlene Marte Furment2, Jyoti Verma3 and Keerthana Jyotheeswara Pillai4, 1University of California Riverside School of Medicine, Riverside, CA, 2SUNY Upstate University Hospital, Syracuse, NY, 3Saint Peter's University Hospital, New Brunswick, NJ, 4Kilpauk Medical College, Chennai, India, New Brunswick, NJ

Meeting: ACR Convergence 2022

Keywords: ANCA associated vasculitis, Cardiovascular, Myocardial Infarction, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – ANCA-Associated Poster I: Epidemiology, Outcomes, and Classification

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Systemic vasculitis is a group of uncommon conditions characterized by inflammation of blood vessels, leading to organ ischemia and necrosis. Although several rheumatological disorders such as SLE and Rheumatoid Arthritis are known to increase the risk of myocardial infarction (MI), it is currently unknown if systemic vasculitis is linked to MI. Therefore, we conducted this study to explore the association between Vasculitis and MI.

Methods: To reflect the epidemiology of vasculitis, we included adult patients admitted to teaching hospitals who were more than 40 years of age. For patients with Takayasu Arteritis (TA) and Eosinophilic Granulomatosis with Polyangiitis (EGPA) we included patients above the age of 18. Relevant variables were extracted from the National Inpatient Sample (NIS) using ICD-10 codes from the NIS from 2016 to 2019. We used inverse probability weighting (IPW) with the vasculitis of interest as the treatment and MI as the outcome while adjusting for age, sex, race, family history of MI, Hyperlipidemia, Hypertension, Diabetes Mellitus, Nicotine Use, and Obesity. All the covariates were fully balanced.

Results: The prevalence of MI was higher in Polyarteritis Nodosa (PAN) and Takayasu Arteritis when compared with controls. The prevalence of MI was lower in EGPA, Giant Cell Arteritis (GCA), Microscopic Polyangiitis (MPA) and GPA when compared with controls. On IPW analysis PAN, Takayasu Arteritis, EGPA, GCA and Microscopic Polyangiitis was not statistically significant for MI (Table 1 and Table 2). GPA and microscopic polyangiitis showed a slightly statistically significant negative association with MI.

Conclusion: The causal link between vasculitis and MI has been proposed by small cohort studies and case reports. One prospective study showed an increased risk of MI with GPA (HR 1.86, 95% CI 1.05-3.31). In another study it was shown that Type 2 MI was more frequently GCA-related than GCA-unrelated (80% vs. 16.7%, p = 0.080), and GCA diagnosis was the only identified triggering factor in 75% of patients with GCA-related Type 2 MI. Some case reports implicate PAN, Takayasu arteritis, MPA and EGPA with MI. However, our extensive study shows that none of the Large-Vessel Vasculitis, ANCA associated Vasculitis and PAN are independently associated with increased risk of MI. The negative association of GPA and microscopic polyangiitis with MI demonstrates only a weak association and has no clinical relevance. Therefore, patients with Large-Vessel Vasculitis, ANCA Associated Vasculitis and PAN should be managed similarly to general population in terms of preventive cardiovascular disease. Key limitations of our study are the retrospective nature, reliance on ICD codes, and the potential for unmeasured confounding.

Supporting image 1

Table 1. Descriptive Data

Supporting image 2

Table 2. Average Treatment Effects for Myocardial Infarction in Large Vessel vasculitis, Polyarteritis Nodosa and ANCA-associated Vasculitis


Disclosures: K. Raj, None; M. Marte Furment, None; J. Verma, None; K. Jyotheeswara Pillai, None.

To cite this abstract in AMA style:

Raj K, Marte Furment M, Verma J, Jyotheeswara Pillai K. Is Systemic Vasculitis a Risk Factor for Myocardial Infarction? A Retrospective Cohort Study from the National Inpatient Sample [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/is-systemic-vasculitis-a-risk-factor-for-myocardial-infarction-a-retrospective-cohort-study-from-the-national-inpatient-sample/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-systemic-vasculitis-a-risk-factor-for-myocardial-infarction-a-retrospective-cohort-study-from-the-national-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology